Pharming To Acquire Abliva And Mitochondrial Disease ‘Potential Blockbuster’ Asset

 
• By Andrew McConaghie
  
mitochondria
KL1333 targets mitochondria dysfunction • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Therapy Areas